Back to News

³Ô¹Ï±¬ÁÏ Announces Clinical Study Training Application

³Ô¹Ï±¬ÁÏ Study Training unifies learning management and clinical operations for integrated and
automated training and real-time inspection readiness

BARCELONA, Spain ¡ª 7 June 2022 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced ³Ô¹Ï±¬ÁÏ Study Training, a new application that brings together research sites, CROs, and sponsors into a single platform for end-to-end clinical study training. Organizations using ³Ô¹Ï±¬ÁÏ Study Training can ensure all trial staff are qualified within required timelines while automating the filing of training certificates into ³Ô¹Ï±¬ÁÏ eTMF for real-time inspection readiness.

¡°³Ô¹Ï±¬ÁÏ continues to collaborate closely with the industry to identify gaps in key processes across clinical development and deliver innovations that can improve operational efficiency,¡± said Ed Leftin, director, information technology at Ora, Inc. ¡°The ability to use existing data and content in ³Ô¹Ï±¬ÁÏ Clinical Suite to create training, from study start to conduct, can streamline study execution and improve compliance.¡±

³Ô¹Ï±¬ÁÏ Study Training builds on ³Ô¹Ï±¬ÁÏ¡¯s experience working with more than 450 companies using ³Ô¹Ï±¬ÁÏ Clinical Platform applications and learnings from hundreds of ³Ô¹Ï±¬ÁÏ Training implementations. Life sciences companies can now address the long-standing industry challenge of training study staff and site personnel in an efficient and compliant way.

³Ô¹Ï±¬ÁÏ¡¯s complete and connected solution will allow life sciences companies to leverage current clinical master data and content to remove issues like redundant information, manual data entry, and siloed processes. ³Ô¹Ï±¬ÁÏ Study Training automates assignment distribution, protocol amendment management, and training certificate filing for increased efficiency and reduced end of study reconciliation.

¡°As studies evolve and reach new levels of complexity, companies need a streamlined and integrated training system that can scale with the demands of today¡¯s trials,¡± said Shad Ayoub, senior director, ³Ô¹Ï±¬ÁÏ Study Training. ¡°³Ô¹Ï±¬ÁÏ Study Training will deliver a fundamentally better experience to sites, CROs, and sponsors.¡±

³Ô¹Ï±¬ÁÏ Study Training will be available to early adopters in fall 2022. To learn more about ³Ô¹Ï±¬ÁÏ Study Training, visit veeva.com/eu/VaultStudyTraining.

Additional Information
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veeva_eu on Twitter:

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world¡¯s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

³Ô¹Ï±¬ÁÏ Forward-looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2022, which you can find (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at .

###

Contact:

Deivis Mercado
³Ô¹Ï±¬ÁÏ Systems
925-226-8821
deivis.mercado@veeva.com

Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems
+49 6950955486
jeremy.whittaker@veeva.com

Powerful Community, Fresh Ideas

Copenhagen | 28-29 May, 2026

Learn more